Product availability

Click on your region on the map below to view our partners in your country.

Map

Distribution partners for Australia and New Zealand

Australia
Device Technologies Australia Pty Ltd	Bead BlockDC Bead

If your country or product is not listed in this region, please contact Biocompatibles directly.

Distribution partners for Asia

Brunei Darussalam
Transmedic	Bead BlockDC Bead
China
SciClone Pharmaceutical International Inc.	DC Bead
Hong Kong
Pacific Medical	DC BeadPrecision Bead
Indonesia
Transmedic	Bead BlockDC Bead
Malaysia
Transmedic Healthcare Sdn Bhd	Bead BlockDC Bead
Philippines
Transmedic	Bead BlockDC Bead
Singapore
Transmedic	Bead BlockDC Bead
Taiwan
Taiwan United Medical Inc	DC Bead
Thailand
Transmedic	Bead BlockDC Bead
Viet Nam
Transmedic	Bead BlockDC Bead

If your country or product is not listed in this region, please contact Biocompatibles directly.

Distribution partners for India & Middle East

India
Eisai Pharmaceuticals India Private Limited	Bead BlockDC Bead
Jordan
Innomedics	Bead BlockDC Bead
United Arab Emirates
Xenith	Bead BlockDC Bead

If your country or product is not listed in this region, please contact Biocompatibles directly.

Distribution partners for Africa

South Africa
Paragmed	Bead BlockDC Bead

If your country or product is not listed in this region, please contact Biocompatibles directly.

Distribution partners for Latin America

Brazil
Terumo Medical do Brasil Ltda	Bead BlockDC Bead
Chile
Terumo Chile Ltda.	Bead BlockDC Bead
Colombia
Terumo Colombia Andina S.A.S.	Bead BlockDC Bead
Mexico
Terumo Medical de Mexico S.A. de C.V.	Bead BlockDC Bead

If your country or product is not listed in this region, please contact Terumo Latin America Corporation.

Distribution partners for Europe

Europe
Terumo Europe NV	Bead BlockDC BeadDC Bead M1

If your country or product is not listed in this region, please contact Biocompatibles directly.

Distribution partners for Canada

Canada
Sorin Group	Bead BlockDC BeadDC Bead M1

If your country or product is not listed in this region, please contact Biocompatibles directly.

Distribution for USA

United States
Biocompatibles, Inc.	Bead Block USALC BeadLC Bead M1

Regulatory notices and product safety data

Worldwide (excluding USA)

Bead Block™ is CE marked and indicated for the treatment of a variety of hypervascular tumours (including Uterine Fibroids) and arteriovenous malformations (AVMs). For full prescribing information please refer to Bead Block instructions for use.

DC Bead^® is CE marked and is indicated for the treatment of malignant hypervascular tumours and loading with doxorubicin drug. DC Bead^® is also indicated for loading with irinotecan for the treatment of metastatic colorectal cancer (mCRC). Both indications may not be available in your territory. For full prescribing information please refer to DC Bead instructions for use.

DC Bead^M1™ is indicated for loading with irinotecan for the treatment of metastatic colorectal cancer (mCRC). For full prescribing information please refer to DC Bead M1 instructions for use.

USA

In the USA, Bead Block™ is indicated for the treatment of hypervascular tumors and arteriovenous malformations (AVMs). For full prescribing information please refer to Bead Block USA Instructions for use.

LC Bead™ is cleared by the FDA for the embolization of hypervascular tumors and arteriovenous malformations (AVMs). For full prescribing information please refer to LC Bead instructions for use.

LC Bead M1™ is cleared by the FDA for the embolization of hypervascular tumors and arteriovenous malformations (AVMs). For full prescribing information please refer to LC Bead ^M1 instructions for use.

DC Bead is not currently available for sale or distribution in the USA. Both indications may not be available in your territory.

DC Bead^M1 is not currently available for sale or distributions in the USA.

Canada

DC Bead^® with doxorubicin is indicated for trans-arterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC). DC Bead are also intended to be loaded with irinotecan for the purpose of embolization of vessels supplying malignant colorectal cancer metastasised to the liver (mCRC), and delivery of a local, controlled, sustained dose of irinotecan to the mCRC. For full prescribing information please refer to DC Bead Canada Instructions for Use

DC Bead^M1 is primarily intended as an embolic agent to treat vessels supplying malignant colorectal cancer metastasised to the liver (mCRC). DC Bead^M1 is also compatible with irinotecan, which can be loaded prior to embolisation and then, as a secondary action, elute a local, controlled and sustained dose to the mCRC after embolisation. For full prescribing information please refer to DC Bead^M1 Canada Instructions for Use

Tawain

DC Bead is approved by the Department of Health and is intended to be loaded with Mayne (Hospira) doxorubicin HCI for the purpose of embolisation of vessels supplying malignant hypervascularised tumour(s), and delivery of a local, controlled, sustained dose of doxorubicin. DC Bead is also indicated for the embolisation of nidus vessels without medication. Approved size ranges in Taiwan are 300-500µm and 500-700µm.

Hong Kong

PRECISION Bead™ is indicated for the delivery of Doxorubicin, a chemotherapeutic agent for the treatment of malignant hypervascular tumours, where Trans Arterial Embolisation (TAE) is not contraindicated.